Skip to content
★ Sign in to follow
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. Stock: price and insider trades · United States

US·Mcap US$5MHealth Care

No insider purchase over the last 90 days. The latest, by TOWERS CHRISTOPHER, was filed 06 Oct 2023.

Intelligent Bio Solutions Inc.: what insiders have been doing

Every trade that managers of Intelligent Bio Solutions Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. From 27 October 2025 to 27 October 2026, the disclosure feed for Intelligent Bio Solutions Inc. logged 8 filings by 6 insiders.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

With 8 filings in twelve months, the company is quieter than the median of 24 filings across the 3,171 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 14 purchases and 31 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 30 June 2026), the company reported revenue of 4.2 m USD and net income of -12.4 m USD.

There has been no open-market purchase by an insider of Intelligent Bio Solutions Inc. for at least a year. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
66
Thresholds
n/a
Buy Volume
€73,683
14 ops. · all time
Sell Volume
€6M
31 ops. · all time

Since the insiders bought

  • Filed 05 Sept 2023 · 1160 days ago · €85
    -93.5%
    Entry US$198.00 · Close at T+365 US$12.90
  • Filed 24 Jun 2022 · 1598 days ago · €3,076
    -81.4%
    Entry US$1,788.00 · Close at T+365 US$332.40
  • Filed 03 Jan 2022 · 1770 days ago · €6,140
    -86.0%
    Entry US$3,936.00 · Close at T+365 US$552.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2026

FY ended June 2026 · cache

US$1.50
Analyst consensus
1 analysts
·
US$12.00Target US$12.00(+700%)US$12.00
Income statement
RevenueUS$4.2M
Gross profitUS$2M49% margin
EBITDA-US$11.3M-268% margin
Net income-US$12.4M-294.9% margin
Valuation
P/Book0.8x
Beta4.30
Balance sheet & cash
Market capUS$5M
Total debtUS$1.8M
Free Cash Flow-US$12.1M
Debt / Equity34%
Profitability & ownership
ROE-307.7%
ROA-76.2%
% insiders2.7%
% institutions5.5%
Last declaration on 20 March 2026
Declarations66 total
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    21,350 shares0Common StockSEC:0001493152-26-011917:1
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    21,350 shares0Common StockSEC:0001493152-26-011913:1
  • ◆
    DirectorExecutives
    0SEC
    5,000 shares0Common StockSEC:0001493152-26-011920:0
  • ◆
    DirectorExecutives
    0SEC
    5,000 shares0Common StockSEC:0001493152-26-011918:0
  • ◆
    DirectorExecutives
    0SEC
    5,000 shares0Common StockSEC:0001493152-26-011916:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    9,150 shares0Common StockSEC:0001493152-26-011917:0
  • ◆
    DirectorExecutives
    0SEC
    5,000 shares0Common StockSEC:0001493152-26-011915:0
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    9,150 shares0Common StockSEC:0001493152-26-011913:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    34,500 shares0Common StockSEC:0001641172-25-001733:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    34,500 shares0Common StockSEC:0001493152-24-038573:0
  • ◆
    Chief Executive OfficerExecutives
    0SEC
    40,000 shares0Common StockSEC:0001493152-24-038576:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    9,394 sharesCommon StockSEC:0001493152-24-010846:0
  • ▲
    DirectorExecutives
    0SEC
    9,090 sharesCommon StockSEC:0001493152-23-036582:0
    Canonical exit: 2 Jan 2024 (T+90)
  • ▲
    Chief Financial OfficerExecutives
    0SEC
    112,727 sharesCommon StockSEC:0001493152-23-036581:0
    Canonical exit: 2 Jan 2024 (T+90)
  • ▲
    CEOExecutives
    93 USD27SEC
    50 shares@ US$1.8532.5% of flowCommon Stock, par value $0.01 per shareSEC:0001493152-23-031612:1
    Canonical exit: 30 Nov 2023 (T+90)
  • ▲
    CEOExecutives
    192 USD30SEC
    100 shares@ US$1.92100.0% of flowCommon Stock, par value $0.01 per shareSEC:0001493152-23-031612:0
    Canonical exit: 29 Nov 2023 (T+90)
  • ●
    Chief Financial OfficerExecutives
    13,914 USD27SEC
    2,399 shares@ US$5.80100.0% of flowCommon StockSEC:0001493152-23-024239:0
  • ◆
    Interim CEO and ChairpersonExecutives
    0SEC
    75,000 shares0Common Stock, par value $0.01 per shareSEC:0001493152-22-028189:0
  • ◆
    DirectorExecutives
    0SEC
    15,000 shares0Common Stock, par value $0.01 per shareSEC:0001493152-22-028194:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    75,000 shares0Common Stock, par value $0.01 per shareSEC:0001493152-22-028185:0
  • ◆
    DirectorExecutives
    0SEC
    15,000 shares0Common Stock, par value $0.01 per shareSEC:0001493152-22-028191:0
  • ◆
    DirectorExecutives
    0SEC
    15,000 shares0Common Stock, par value $0.01 per shareSEC:0001493152-22-028193:0
  • ◆
    DirectorExecutives
    0SEC
    15,000 shares0Common Stock, par value $0.01 per shareSEC:0001493152-22-028190:0
  • ◆
    PresidentExecutives
    0SEC
    80,000 shares0Common Stock, par value $0.01 per shareSEC:0001493152-22-028196:0
  • ▲
    Chief Financial OfficerExecutives
    3,249 USD24SEC
    5,000 shares@ US$0.64985.9% of flowCommon StockSEC:0001493152-22-017644:0
    Canonical exit: 20 Sept 2022 (T+90)

25 of 66 declarations

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. is a company listed on the XNAS market, focused on developing innovative biological solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations